SCHEMBL16375201

SCHEMBL16375201

O=C(NC(Cc1ccc(-c2ncc(-c3ccccc3)cn2)cc1)C(=O)NCCCO)c1cccs1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.53
▸ HSPA1A P0DMV8 1/20 0.51
▸ HSPA5 P11021 1/20 0.51
▸ HSPA9 P38646 1/20 0.51
▸ HSPA2 P54652 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ GRIA1 P42261 4/20 0.44
▸ HPGDS O60760 4/20 0.43
▸ CTSB P07858 1/20 0.43
▸ CTSS P25774 1/20 0.43
▸ CTSK P43235 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ TACR2 P21452 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ KLKB1 P03952 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16375233 0.90 CTSL (0.54) CTSLHSPA1AHSPA5HSPA9HSPA2
SCHEMBL16375202 0.88 L3MBTL1 (0.58) CTSLL3MBTL1GRIA1CTSBCTSS
SCHEMBL16375213 0.85 HSPA1A (0.53) CTSLHSPA1AHSPA5HSPA9HSPA2
SCHEMBL16375203 0.83 CTSL (0.53) CTSLHSPA1AHSPA5HSPA9HSPA2
SCHEMBL17994240 0.81 CTSL (0.53) CTSLHSPA1AHSPA5HSPA9HSPA2
SCHEMBL16375208 0.81 HSPA5 (0.51) CTSLHSPA1AHSPA5HSPA9HSPA2
SCHEMBL16375232 0.77 L3MBTL1 (0.59) CTSLL3MBTL1GRIA1CTSBCTSS
SCHEMBL16375214 0.77 HSPA5 (0.46) CTSLHSPA1AHSPA5HSPA9HSPA2
SCHEMBL17994251 0.76 HSPA5 (0.50) CTSLHSPA1AHSPA5HSPA9HSPA2
SCHEMBL17994243 0.76 HSPA5 (0.50) CTSLHSPA1AHSPA5HSPA9HSPA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150011527-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2015-01-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011527-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R CTSL 1635/4885HSPA1A 2012/4885HSPA5 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback